Gene expression profiling of H9c2 myoblast differentiation towards a cardiac-like phenotype

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Branco, Ana F ^a,b,e   Pereira, Susana P ^a   Gonzalez, Susana ^c   Gusev, Oleg ^d   Rizvanov, Albert A ^d   Oliveira, Paulo J ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^d KAZAN FEDERAL UNIVERSITY   (Russian Federation)

^e MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CARNITINE PALMITOYLTRANSFERASE I; CREATINE KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; PHOSPHOLAMBAN; PROTEIN BCL 2; RETINOIC ACID; RYANODINE RECEPTOR; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE 2; TROPONIN T; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; EMBRYO CELL; ENERGY YIELD; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; GLYCOLYSIS; HEART CONTRACTION; MITOCHONDRIAL RESPIRATION; MYOBLAST; NONHUMAN; PHENOTYPE; RAT; RESPIRATORY CHAIN; UPREGULATION; ANIMAL; CARDIAC MYOBLAST; CELL LINE; CELL SHAPE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; CELL SHAPE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; METABOLIC NETWORKS AND PATHWAYS; MYOBLASTS, CARDIAC; PHENOTYPE; RATS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRETINOIN;

EID: 84938700291     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0129303     Document Type: Article

References (37)

1. Hescheler J, Meyer R, Plant S, Krautwurst D, Rosenthal W, Schultz G. Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart. Circ Res. 1991; 69 (6):1476-1486. PMID: 1683272
2. Kimes BW, Brandt BL. Properties of a clonal muscle cell line from rat heart. Exp Cell Res. 1976; 98 (2):367-381. PMID: 943302
3. Sardao VA, Oliveira PJ, Holy J, Oliveira CR, Wallace KB. Vital imaging of H9c2 myoblasts exposed to tert-butylhydroperoxide-characterization of morphological features of cell death. BMC Cell Biol. 2007; 8:11. doi: 10.1186/1471-2121-8-11 PMID: 17362523
4. Menard C, Pupier S, Mornet D, Kitzmann M, Nargeot J, Lory P. Modulation of L-type calcium channel expression during retinoic acid-induced differentiation of H9C2 cardiac cells. J Biol Chem. 1999; 274 (41):29063-29070. PMID: 10506158
5. Watkins SJ, Borthwick GM, Arthur HM. The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro. In Vitro Cell Dev Biol Anim. 2011; 47(2):125-131. doi: 10.1007/s11626-010-9368-1 PMID: 21082279
6. Branco AF, Pereira SL, Moreira AC, Holy J, Sardao VA, Oliveira PJ. Isoproterenol cytotoxicity is dependent on the differentiation state of the cardiomyoblast H9c2 cell line. Cardiovasc Toxicol. 2011; 11 (3):191-203. doi: 10.1007/s12012-011-9111-5 PMID: 21455642
7. Branco AF, Sampaio SF, Moreira AC, Holy J, Wallace KB, Baldeiras I, et al. Differentiation-dependent doxorubicin toxicity on H9c2 cardiomyoblasts. Cardiovasc Toxicol. 2012; 12(4):326-340. doi: 10.1007/s12012-012-9177-8 PMID: 22744233
8. Branco AF, Sampaio SF, Wieckowski MR, Sardao VA, Oliveira PJ. Mitochondrial disruption occurs downstream from beta-adrenergic overactivation by isoproterenol in differentiated, but not undifferentiated H9c2 cardiomyoblasts: differential activation of stress and survival pathways. Int J Biochem Cell Biol. 2013; 45(11):2379-2391. doi: 10.1016/j.biocel.2013.08.006 PMID: 23958426
9. Pereira SL, Ramalho-Santos J, Branco AF, Sardao VA, Oliveira PJ, Carvalho RA. Metabolic remodeling during H9c2 myoblast differentiation: relevance for in vitro toxicity studies. Cardiovasc Toxicol. 2011; 11(2):180-190. doi: 10.1007/s12012-011-9112-4 PMID: 21431998
10. Sardao VA, Oliveira PJ, Holy J, Oliveira CR, Wallace KB. Doxorubicin-induced mitochondrial dysfunction is secondary to nuclear p53 activation in H9c2 cardiomyoblasts. Cancer Chemother Pharmacol. 2009; 64(4):811-827. doi: 10.1007/s00280-009-0932-x PMID: 19184017
11. Vichai V, Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc. 2006; 1(3):1112-1116. doi: 10.1038/nprot.2006.179 PMID: 17406391
12. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-254. PMID: 942051
13. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 2003; 19(2):185-193. PMID: 12538238
14. Comelli M, Domenis R, Bisetto E, Contin M, Marchini M, Ortolani F, et al. Cardiac differentiation promotes mitochondria development and ameliorates oxidative capacity in H9c2 cardiomyoblasts. Mitochondrion. 2011; 11(2):315-326. doi: 10.1016/j.mito.2010.12.007 PMID: 21147273
15. di Giacomo V, Rapino M, Sancilio S, Patruno A, Zara S, Di Pietro R, et al. PKC-delta signalling pathway is involved in H9c2 cells differentiation. Differentiation. 2010; 80(4-5):204-212. doi: 10.1016/j.diff.2010.06.002 PMID: 20817341
16. Sardao VA, Oliveira PJ, Holy J, Oliveira CR, Wallace KB. Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets. Cell Biol Toxicol. 2009; 25 (3):227-243. doi: 10.1007/s10565-008-9070-1 PMID: 18386138
17. Yu XY, Geng YJ, Liang JL, Lin QX, Lin SG, Zhang S, et al. High levels of glucose induce apoptosis in cardiomyocyte via epigenetic regulation of the insulin-like growth factor receptor. Exp Cell Res. 2010; 316(17):2903-2909. doi: 10.1016/j.yexcr.2010.07.004 PMID: 20633551
18. De Angelis A, Piegari E, Cappetta D, Marino L, Filippelli A, Berrino L, et al. Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function. Circulation. 2010; 121(2):276-292. doi: 10.1161/CIRCULATIONAHA.109.895771 PMID: 20038740
19. Pagano M, Naviglio S, Spina A, Chiosi E, Castoria G, Romano M, et al. Differentiation of H9c2 cardiomyoblasts: The role of adenylate cyclase system. J Cell Physiol. 2004; 198(3):408-416. doi: 10.1002/jcp.10420 PMID: 14755546
20. Kuzmenkin A, Liang H, Xu G, Pfannkuche K, Eichhorn H, Fatima A, et al. Functional characterization of cardiomyocytes derived from murine induced pluripotent stem cells in vitro. FASEB J. 2009; 23 (12):4168-4180. doi: 10.1096/fj.08-128546 PMID: 19703934
21. Schrauwen P, Hoeks J, Schaart G, Kornips E, Binas B, Van De Vusse GJ, et al. Uncoupling protein 3 as a mitochondrial fatty acid anion exporter. FASEB J. 2003; 17(15):2272-2274. doi: 10.1096/fj.03-0515fje PMID: 14525936
22. Schrauwen P, Hesselink M. UCP2 and UCP3 in muscle controlling body metabolism. J Exp Biol. 2002; 205(Pt 15):2275-2285. PMID: 12110661
23. Lee JK, Kim KH. Roles of acetyl-CoA carboxylase beta in muscle cell differentiation and in mitochondrial fatty acid oxidation. Biochem Biophys Res Commun. 1999; 254(3):657-660. doi: 10.1006/bbrc.1998.0113 PMID: 9920796
24. Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem J. 1992; 281 (Pt 1):21-40. PMID: 1731757
25. Schopf G, Rumpold H, Muller MM. Alterations of purine salvage pathways during differentiation of rat heart myoblasts towards myocytes. Biochim Biophys Acta. 1986; 884(2):319-325. PMID: 3768422
26. Chung S, Arrell DK, Faustino RS, Terzic A, Dzeja PP. Glycolytic network restructuring integral to the energetics of embryonic stem cell cardiac differentiation. J Mol Cell Cardiol. 2010; 48(4):725-734. doi: 10.1016/j.yjmcc.2009.12.014 PMID: 20045004
27. Huang B, Wu P, Bowker-Kinley MM, Harris RA. Regulation of pyruvate dehydrogenase kinase expression by peroxisome proliferator-activated receptor-alpha ligands, glucocorticoids, and insulin. Diabetes. 2002; 51(2):276-283. Epub 2002/01/29. PMID: 11812733
28. Wu P, Blair PV, Sato J, Jaskiewicz J, Popov KM, Harris RA. Starvation increases the amount of pyruvate dehydrogenase kinase in several mammalian tissues. Arch Biochem Biophys. 2000; 381(1):1-7. Epub 2000/10/06. doi: S0003-9861(00)91946-5 [pii]doi: 10.1006/abbi.2000.1946 PMID: 11019813
29. Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, Kelly DP. Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest. 2000; 106(7):847-856. doi: 10.1172/JCI10268 PMID: 11018072
30. Arany Z, Lebrasseur N, Morris C, Smith E, Yang W, Ma Y, et al. The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab. 2007; 5(1):35-46. doi: 10.1016/j.cmet.2006.12.003 PMID: 17189205
31. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jager S, et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell. 2006; 127(2):397-408. doi: 10.1016/j.cell.2006.09.024 PMID: 17055439
32. Molina CE, Leroy J, Richter W, Xie M, Scheitrum C, Lee IO, et al. Cyclic adenosine monophosphate phosphodiesterase type 4 protects against atrial arrhythmias. J Am Coll Cardiol. 2012; 59(24):2182-2190. doi: 10.1016/j.jacc.2012.01.060 PMID: 22676938
33. Bohm M, Morano I, Pieske B, Ruegg JC, Wankerl M, Zimmermann R, et al. Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium. Circ Res. 1991; 68(3):689-701. PMID: 1660359
34. Xu Q, Konta T, Furusu A, Nakayama K, Lucio-Cazana J, Fine LG, et al. Transcriptional induction of mitogen-activated protein kinase phosphatase 1 by retinoids. Selective roles of nuclear receptors and contribution to the antiapoptotic effect. J Biol Chem. 2002; 277(44):41693-41700. doi: 10.1074/jbc.M207095200 PMID: 12186877
35. Charron F, Tsimiklis G, Arcand M, Robitaille L, Liang Q, Molkentin JD, et al. Tissue-specific GATA factors are transcriptional effectors of the small GTPase RhoA. Genes Dev. 2001; 15(20):2702-2719. doi: 10.1101/gad.915701 PMID: 11641276
36. Xu Y, Li N, Xiang R, Sun P. Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence. Trends Biochem Sci. 2014; 39(6):268-276. doi: 10.1016/j.tibs.2014.04.004 PMID: 24818748
37. Peifer C, Alessi DR. Small-molecule inhibitors of PDK1. ChemMedChem. 2008; 3(12):1810-1838. doi: 10.1002/cmdc.200800195 PMID: 18972468